Atrium Health Receives the Johnson & Johnson Vaccine
March 24, 2021
Shortly after being approved for Emergency Use by the FDA, Atrium Health received its first doses of the Johnson & Johnson vaccine. A recent article by The Business Journals titled "Atrium Health Receives First Doses of Johnson & Johnson's Single-Shot Vaccine for COVID-19"
states that it received 6,000 doses and plans to target educators first, with other groups following suit as supply becomes more readily available. Atrium Health now administers every vaccine, Pfizer-BioNTech, Moderna, and Johnson & Johnson.
The Chief Medical Officer, Dr. Gary Little, says that having access to another vaccine will create more opportunities to increase the number of vaccination sites, allowing more people to get vaccinated quickly. "The more vaccines we administer, the more we will also help stop the spread of COVID-19 and get us closer to community immunity, which will ultimately allow us to get back to the people and places we love."
The Jonson & Johnson vaccine was authorized for emergency use in late February and the pharmaceutical company plans to deliver more than 20 million doses throughout the country in March. As the vaccine only requires one dose and can be stored at regular refrigeration temperatures, Atrium says it'll certainly help with logistics. A phase 3 study shows the vaccine is 85% effective in preventing severe cases, with protection beginning to take effect about four weeks after getting the shot.
Atrium Health is partnering with local groups such as Honeywell International Inc., Tepper Sports & Entertainment, and Charlotte Motor Speedway to run massive vaccination sites as part of their goal to reach 1 million vaccinations by July 4th.
For more information, make sure to click here: Atrium Health Receives First Doses of Johnson & Johnson's Single-Shot Vaccine for COVID-19